
By BY SHERYL GAY STOLBERG, CHRIS HAMBY AND REBECCA R. RUIZ from NYT U.S.
https://ift.tt/2S3ZwOf
Emergent BioSolutions faces scrutiny in Congress for ruining Covid-19 vaccines and securing lucrative federal contracts. Executives will appear before some lawmakers who benefited from the company’s spending.
No comments:
Post a Comment